Reading cancer's blueprint

Article metrics

Coinciding with last month's annual meeting of the American Society of Clinical Oncology, at least one business launched with a plan to use genetic information from patient tumors to help guide treatment. Michael Eisenstein investigates.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Roychowdhury, S. et al. Sci. Transl. Med. 3, 111ra121 (2011).

  2. 2

    Palmer, G.A. et al. Abstract no. 10590 presented at the American Society for Clinical Oncology Meeting, June 1–5, 2012 http://abstract.asco.org/AbstView_114_99137.html

  3. 3

    Gerlinger, M. et al. N. Engl. J. Med. 366, 883–892 (2012).

  4. 4

    Poste, G. Nature 469, 156–157 (2011).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Eisenstein, M. Reading cancer's blueprint. Nat Biotechnol 30, 581–584 (2012) doi:10.1038/nbt.2292

Download citation

Further reading